RESILIENCE GOVERNMENT SERVICES, INC.
SAN DIEGO, CA

Resilience Government Services, Inc., formerly known as OLOGY BIOSERVICES, INC., is an integrated biopharmaceutical entity specializing in the development and manufacturing of biopharmaceuticals with a focus on advanced medical countermeasures. Founded on June 19, 2009, in Florida, this company has successfully secured over $500 million through US Government contracts and grants to support drugs and biologics critical for healthcare and national security. The organization collaborates actively with the U.S. Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), and National Institute of Allergy and Infectious Diseases (NIAID) to enhance medical countermeasures for protecting American warfighters. Resilience Government Services boasts proprietary platform technologies crucial for producing biologic products, including proteins, monoclonal antibodies, and vaccines. The company's state-of-the-art manufacturing facility spans 183,000 square feet at a BSL-3 level, compliant with cGMP standards and certified under ISO 9001. Headquartered in San Diego, CA, though originally incorporated in Florida with its home state designation as Delaware, the company employs over 185 individuals across various U.S. locations. Its strategic partnerships have been vital in accomplishing a notable $400+ million contract awarded by the DoD on March 30, 2013, to build and operate an MCM ADM facility tailored for the military's requirements. The current leadership includes President Sandy Mahatme, Director Ori Solomon, and Director Rahul Singhvi, Sc.D. With its commitment to delivering top-quality biopharmaceutical products, Resilience Government Services continues to innovate within the field of biotechnology by advancing development processes and ensuring high product integrity throughout manufacturing.